| 000 | 01625 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513145713.0 | ||
| 264 | 0 | _c19980807 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0090-3493 | ||
| 024 | 7 |
_a10.1097/00003246-199807000-00021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKozek-Langenecker, S A | |
| 245 | 0 | 0 |
_aAnticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration. _h[electronic resource] |
| 260 |
_bCritical care medicine _cJul 1998 |
||
| 300 |
_a1208-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAPACHE |
| 650 | 0 | 4 |
_aAlprostadil _xadministration & dosage |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 |
_aCritical Care _xmethods |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemofiltration _xmethods |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aPlatelet Function Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aKettner, S C | |
| 700 | 1 | _aOismueller, C | |
| 700 | 1 | _aGonano, C | |
| 700 | 1 | _aSpeiser, W | |
| 700 | 1 | _aZimpfer, M | |
| 773 | 0 |
_tCritical care medicine _gvol. 26 _gno. 7 _gp. 1208-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00003246-199807000-00021 _zAvailable from publisher's website |
| 999 |
_c9637303 _d9637303 |
||